Literature DB >> 18406992

Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.

Laurie G Jacobs1.   

Abstract

Warfarin, a vitamin K antagonist, is currently the most extensively used oral anticoagulant world-wide. It is prescribed for a variety of indications and has undergone extensive clinical study. Still, despite wide usage and considerable accumulated data from clinical trials demonstrating efficacy for a variety of thrombotic and thromboembolic conditions, warfarin is underutilized because its management is complex for both patients and physicians. However, despite these limitations, warfarin can be managed with relative safety, even in an elderly population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18406992     DOI: 10.1016/j.ccl.2007.12.010

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  15 in total

1.  Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans.

Authors:  Michael A Lane; Angelique Zeringue; Jay R McDonald
Journal:  Am J Med       Date:  2014-03-19       Impact factor: 4.965

2.  Drug interaction presenting as acute abdomen.

Authors:  Rajesh Pendlimari; Rajeswari Anaparthy; Aravind Sugumar
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-02-06

3.  Bleeding events attributable to concurrent use of warfarin and other medications in high-risk elderly: meta-analysis and Italian population-based investigation.

Authors:  Rosanna Irene Comoretto; Federico Rea; Ersilia Lucenteforte; Alessandro Mugelli; Gianluca Trifirò; Silvia Cascini; Giuseppe Roberto; Alessandro Chinellato; Amelia Filippelli; Giovanni Corrao
Journal:  Eur J Clin Pharmacol       Date:  2018-05-07       Impact factor: 2.953

Review 4.  A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks.

Authors:  Beata Bajorek
Journal:  Ther Adv Drug Saf       Date:  2011-04

5.  A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.

Authors:  Leanne Stafford; Gregory M Peterson; Luke R E Bereznicki; Shane L Jackson
Journal:  BMC Health Serv Res       Date:  2011-01-25       Impact factor: 2.655

6.  A cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol.

Authors:  Beata Bajorek; Parker Magin; Sarah Hilmer; Ines Krass
Journal:  BMC Health Serv Res       Date:  2014-02-07       Impact factor: 2.655

7.  Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome.

Authors:  Wen-Chi Chen; Yan-Hua Chen; Ping-I Hsu; Feng-Woei Tsay; Hoi-Hung Chan; Jin-Shiung Cheng; Kwok-Hung Lai
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

Review 8.  Use of anticoagulants in elderly patients: practical recommendations.

Authors:  Helia Robert-Ebadi; Grégoire Le Gal; Marc Righini
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

9.  Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance.

Authors:  Nancy El-Helou; Amal Al-Hajje; Rola Ajrouche; Sanaa Awada; Samar Rachidi; Salam Zein; Pascale Salameh
Journal:  Vasc Health Risk Manag       Date:  2013-03-01

10.  Bupropion-warfarin combination: a serious complication.

Authors:  Amar D Bavle; Akshay S Phatak
Journal:  Indian J Psychol Med       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.